Aziz recently pioneered a new technology, called MAS-seq, that timestamps RNA sequencing data, allowing researchers to better investigate individual cells’ behaviors at a specific moment in time, making it possible to capture complex cellular dynamics, such as how tumor cells evolve. Aziz will use his BroadIgnite funding to take MAS-seq to the next level, ensuring its accuracy and rigorousness for studying disease.

As of 2025, Aziz is the director of research and development at the Genomics Platform and director of the Broad’s Methods Development Lab, which he launched in 2022.